Fig. 7From: Macrophage cell membrane-based nanoparticles: a new promising biomimetic platform for targeted delivery and treatmentA Preparation and characterization of RVG/TPP-MASLNs-GS. B In vivo brain-targeting ability. Biodistribution of DIR contained in various formulations determined by IVIS Lumina II. C Representative swimming path tracings of different groups. Adapted with permission from [127], copyright © 1999–2022 John Wiley & Sons, Inc.Back to article page